CA2709771A1
(en)
*
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
US7164009B2
(en)
|
2000-09-15 |
2007-01-16 |
Genentech, Inc. |
Pro9821 polypeptides
|
US20030124534A1
(en)
|
2000-12-08 |
2003-07-03 |
Luca Rastelli |
Method of detecting and treating Tuberous Sclerosis Complex associated disorders
|
US20060035237A1
(en)
*
|
2002-08-26 |
2006-02-16 |
Markowitz Sanford D |
Methods and compositions for categorizing patients
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
WO2002098356A2
(en)
*
|
2001-06-05 |
2002-12-12 |
Exelixis Inc. |
Ppp2cs as modifiers of the p53 pathway and methods of use
|
AU2002343443A1
(en)
*
|
2001-09-28 |
2003-04-14 |
Whitehead Institute For Biomedical Research |
Classification of lung carcinomas using gene expression analysis
|
CA2470088A1
(en)
*
|
2001-12-20 |
2003-07-03 |
Tularik Inc. |
Identification of an amplified gene and target for drug intervention
|
EP1361433A3
(en)
*
|
2002-04-09 |
2005-02-23 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
|
DE10225144A1
(en)
*
|
2002-05-29 |
2003-12-18 |
Immatics Biotechnologies Gmbh |
Tumor-associated peptides binding to MHC molecules
|
EP1552845A4
(en)
*
|
2002-06-26 |
2006-06-07 |
Takeda Pharmaceutical |
Preventives/remedies for cancer
|
GB0215224D0
(en)
*
|
2002-07-01 |
2002-08-14 |
Inpharmatica Ltd |
Protein
|
US7803370B2
(en)
|
2002-08-30 |
2010-09-28 |
Oncotherapy Science, Inc. |
Method for treating synovial sarcoma
|
AU2003256079A1
(en)
*
|
2002-08-30 |
2004-03-19 |
Japan As Represented By President Of The University Of Tokyo |
Method for treating synovial sarcoma
|
JP2005537810A
(en)
*
|
2002-09-11 |
2005-12-15 |
ジェネンテック・インコーポレーテッド |
Compositions and methods for tumor diagnosis and treatment
|
TW200413725A
(en)
*
|
2002-09-30 |
2004-08-01 |
Oncotherapy Science Inc |
Method for diagnosing non-small cell lung cancers
|
US20060134622A1
(en)
*
|
2002-12-20 |
2006-06-22 |
Meena Augustus |
Amplified cancer target genes useful in diagnosis and thereapeutic screening
|
AU2003292737A1
(en)
*
|
2002-12-24 |
2004-07-22 |
Takeda Pharmaceutical Company Limited |
Preventives/remedies for cancer
|
EP1577322A4
(en)
*
|
2002-12-26 |
2006-01-25 |
Takeda Pharmaceutical |
Novel proteins and use thereof
|
EP1599606A1
(en)
*
|
2003-03-03 |
2005-11-30 |
Arizona Board of Regents on behalf of The University of Arizona |
Protein tyrosine phosphatase - prl-1 a a marker and therapeutic target for pancreatic cancer
|
NZ542490A
(en)
*
|
2003-03-11 |
2008-04-30 |
Univ British Columbia |
Diagnosis of gynecological neoplasms by detecting the levels of oviduct-specific glycoprotein
|
AU2004224448A1
(en)
*
|
2003-03-24 |
2004-10-07 |
Corixa Corporation |
Detection and monitoring of lung cancer
|
AU2003901511A0
(en)
*
|
2003-03-28 |
2003-04-17 |
Bionomics Limited |
Nucleic acid molecules associated with angiogenesis II
|
EP1619499B1
(en)
|
2003-04-25 |
2011-01-05 |
Takeda Pharmaceutical Company Limited |
Novel screening method
|
WO2004097034A2
(en)
*
|
2003-05-02 |
2004-11-11 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 4 (tmprss4)
|
WO2004111197A2
(en)
*
|
2003-06-10 |
2004-12-23 |
Trustees Of Boston University |
Gene expression signatures, methods and compositions for diagnosing disorders of the lung
|
EP2327796A1
(en)
*
|
2003-06-10 |
2011-06-01 |
The Trustees Of Boston University |
Detection methods for disorders of the lung
|
WO2005002417A2
(en)
*
|
2003-06-20 |
2005-01-13 |
Avalon Pharmaceuticals, Inc. |
Cancer -linked gene aas target for chemotherapy
|
CN1867679B
(en)
*
|
2003-07-17 |
2012-10-03 |
环太平洋生物技术有限公司 |
Markers for detection of gastric cancer
|
ES2579836T3
(en)
|
2003-11-06 |
2016-08-17 |
Seattle Genetics, Inc. |
Monomethylvaline compounds capable of conjugation with ligands
|
AU2004298604B2
(en)
*
|
2003-12-15 |
2010-09-23 |
The Regents Of The University Of California |
Molecular signature of the PTEN tumor suppressor
|
JP2008507261A
(en)
*
|
2004-01-27 |
2008-03-13 |
コンピュゲン ユーエスエイ,インク. |
Novel nucleotide and amino acid sequences for lung cancer diagnosis, and assays and methods of use thereof
|
JP2005230011A
(en)
*
|
2004-02-20 |
2005-09-02 |
Samsung Electronics Co Ltd |
Mammary cancer related protein, gene coding the same, and mammary cancer diagnostic method using the protein or the gene
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
US7399469B2
(en)
*
|
2004-03-26 |
2008-07-15 |
Pdl Biopharma, Inc. |
Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer
|
JP2005314397A
(en)
*
|
2004-03-31 |
2005-11-10 |
Mitsubishi Chemicals Corp |
Anti-chondromodulin-1-specific antibody and its use
|
EP1743944A4
(en)
|
2004-04-23 |
2011-01-05 |
Takeda Pharmaceutical |
Novel method of screening
|
DE102004023187A1
(en)
|
2004-05-11 |
2005-12-01 |
Ganymed Pharmaceuticals Ag |
Identification of surface-associated antigens for tumor diagnosis and therapy
|
AU2005249490B2
(en)
|
2004-06-01 |
2010-07-29 |
Genentech, Inc. |
Antibody drug conjugates and methods
|
DE602005020786D1
(en)
|
2004-06-03 |
2010-06-02 |
Takeda Pharmaceutical |
NEW PROTEIN COMPLEX AND APPLICATIONS THEREOF
|
CA2579558A1
(en)
*
|
2004-09-08 |
2006-03-16 |
Ludwig Institute For Cancer Research |
Cancer-testis antigens
|
CA2580141C
(en)
|
2004-09-23 |
2013-12-10 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
US8034578B2
(en)
*
|
2004-10-19 |
2011-10-11 |
Oncotherapy Science, Inc. |
PKP3 oncogene as a prognostic indicator for lung cancer
|
EP1846550A2
(en)
*
|
2005-02-10 |
2007-10-24 |
Centre National De La Recherche Scientifique (Cnrs) |
Use of the mcm8 gene for the preparation of a pharmaceutical composition
|
ES2459466T3
(en)
|
2005-02-25 |
2014-05-09 |
Oncotherapy Science, Inc. |
Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides
|
DE102005013846A1
(en)
|
2005-03-24 |
2006-10-05 |
Ganymed Pharmaceuticals Ag |
Identification of surface-associated antigens for tumor diagnosis and therapy
|
WO2006113467A2
(en)
|
2005-04-14 |
2006-10-26 |
The Trustees Of Boston University |
Diagnostic for lung disorders using class prediction
|
GB0508863D0
(en)
*
|
2005-04-29 |
2005-06-08 |
Astrazeneca Ab |
Peptide
|
ATE525401T1
(en)
*
|
2005-05-13 |
2011-10-15 |
Oxford Biomedica Ltd |
MHC CLASS I AND II PEPTIDE ANTIGENS DERIVED FROM TUMOR ANTIGEN 5T4
|
PT1957539E
(en)
|
2005-12-08 |
2013-06-25 |
Medarex Inc |
Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and their use
|
GB0526498D0
(en)
*
|
2005-12-28 |
2006-02-08 |
Randox Lab Ltd |
Method
|
AU2007223788B2
(en)
|
2006-03-09 |
2012-11-29 |
The Trustees Of Boston University |
Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
|
HUE025989T2
(en)
|
2006-03-21 |
2016-05-30 |
Genentech Inc |
Combinatorial therapy involving alpha5beta1 antagonists
|
JP5298266B2
(en)
*
|
2006-03-31 |
2013-09-25 |
静岡県 |
Evaluation kit for small cell lung cancer
|
JP5114637B2
(en)
*
|
2006-03-31 |
2013-01-09 |
静岡県 |
Determination method of small cell lung cancer
|
KR101351208B1
(en)
|
2006-06-21 |
2014-01-14 |
온코세라피 사이언스 가부시키가이샤 |
Tumor-targeting monoclonal antibodies to fzd10 and uses thereof
|
CA2655933C
(en)
*
|
2006-06-23 |
2014-09-09 |
Alethia Biotherapeutics Inc. |
Polynucleotides and polypeptide sequences involved in cancer
|
EP2050466B1
(en)
|
2006-08-14 |
2015-10-28 |
Chugai Seiyaku Kabushiki Kaisha |
Diagnosis and treatment of cancer using anti-desmoglein-3 antibodies
|
EP1932854A1
(en)
*
|
2006-12-15 |
2008-06-18 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Lysosomal associated membrane protein (LAMP) - like polypeptide, ligands to the same, and use of the same in the frame of detection and purification of human plasmacytoid dendritic cells
|
TWI596109B
(en)
*
|
2007-02-21 |
2017-08-21 |
腫瘤療法 科學股份有限公司 |
Peptide vaccines for cancers expressing tumor-associated antigens
|
AU2008251877A1
(en)
|
2007-05-08 |
2008-11-20 |
Picobella Llc |
Methods for diagnosing and treating prostate and lung cancer
|
CA2688299A1
(en)
*
|
2007-05-29 |
2008-12-18 |
President And Fellows Of Harvard College |
Molecules involved in regulation of osteoblast activity and osteoclast activity, and methods of use thereof
|
SI2182981T1
(en)
|
2007-08-02 |
2013-05-31 |
Gilead Biologics, Inc. |
Methods and compositions for treatment and diagnosis of fibrosis
|
RU2483078C2
(en)
|
2007-08-20 |
2013-05-27 |
Онкотерапи Сайенс, Инк. |
Cdh3-peptide and drug preparation containing it
|
CA2697517A1
(en)
*
|
2007-08-24 |
2009-03-05 |
Oncotherapy Science, Inc. |
Cancer-related genes, cdca5, epha7, stk31 and wdhd1
|
AU2008296927C1
(en)
*
|
2007-09-06 |
2015-08-13 |
Case Western Reserve University |
Methods for diagnosing and treating cancers
|
AU2008302076B2
(en)
|
2007-09-19 |
2015-06-11 |
The Trustees Of Boston University |
Identification of novel pathways for drug development for lung disease
|
AR066170A1
(en)
|
2007-09-26 |
2009-07-29 |
Genentech Inc |
ANTI INTEGRINA ALFA 5 BETA 1
|
ES2532635T3
(en)
|
2008-07-15 |
2015-03-30 |
Genentech, Inc. |
Anthracycline conjugates, process for its preparation and its use as antitumor compounds
|
TW201008574A
(en)
|
2008-08-19 |
2010-03-01 |
Oncotherapy Science Inc |
INHBB epitope peptides and vaccines containing the same
|
MX2011002322A
(en)
*
|
2008-09-09 |
2011-05-10 |
Somalogic Inc |
Lung cancer biomarkers and uses thereof.
|
US10359425B2
(en)
|
2008-09-09 |
2019-07-23 |
Somalogic, Inc. |
Lung cancer biomarkers and uses thereof
|
EP2342334A4
(en)
|
2008-09-29 |
2012-03-14 |
Univ Pennsylvania |
Tumor vascular marker-targeted vaccines
|
SG195571A1
(en)
|
2008-10-22 |
2013-12-30 |
Oncotherapy Science Inc |
Rab6kifl/kif20a epitope peptide and vaccines containing the same
|
JP2012506236A
(en)
*
|
2008-10-24 |
2012-03-15 |
オンコセラピー・サイエンス株式会社 |
Screening method for anti-lung cancer compound or anti-esophageal cancer compound
|
CA3050455A1
(en)
|
2008-11-03 |
2010-06-03 |
Adc Therapeutics Sa |
Antibodies that specifically block the biological activity of a tumor antigen
|
US9495515B1
(en)
|
2009-12-09 |
2016-11-15 |
Veracyte, Inc. |
Algorithms for disease diagnostics
|
US9107935B2
(en)
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
WO2010095461A1
(en)
*
|
2009-02-20 |
2010-08-26 |
国立大学法人東京大学 |
Novel monoclonal antibody, and use thereof
|
JP6051048B2
(en)
|
2009-03-25 |
2016-12-21 |
ジェネンテック, インコーポレイテッド |
Novel anti-α5β1 antibody and use thereof
|
EP2427575B1
(en)
|
2009-05-07 |
2018-01-24 |
Veracyte, Inc. |
Methods for diagnosis of thyroid conditions
|
TW201102081A
(en)
|
2009-05-11 |
2011-01-16 |
Oncotherapy Science Inc |
TTK peptides and vaccines including the same
|
CA2771702A1
(en)
|
2009-08-21 |
2011-02-24 |
Gilead Biologics, Inc. |
Catalytic domains from lysyl oxidase and loxl2
|
JP2013504585A
(en)
|
2009-09-09 |
2013-02-07 |
セントローズ, エルエルシー |
Extracellular targeted drug complex
|
WO2011051271A2
(en)
|
2009-10-26 |
2011-05-05 |
Externautics S.P.A. |
Prostate tumor markers and methods of use thereof
|
US10288617B2
(en)
|
2009-10-26 |
2019-05-14 |
Externautics Spa |
Ovary tumor markers and methods of use thereof
|
US20120322075A1
(en)
*
|
2009-10-26 |
2012-12-20 |
Externautics S.P.A. |
Lung Tumor Markers and Methods of Use Thereof
|
WO2011088163A1
(en)
|
2010-01-14 |
2011-07-21 |
President And Fellows Of Harvard College |
Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination
|
MX2012011901A
(en)
|
2010-04-15 |
2012-11-29 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof.
|
CA3220104A1
(en)
|
2010-06-08 |
2011-12-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
JP5905003B2
(en)
*
|
2010-07-09 |
2016-04-20 |
ソマロジック・インコーポレーテッド |
Lung cancer biomarkers and their use
|
SG2014007454A
(en)
|
2010-08-13 |
2014-07-30 |
Somalogic Inc |
Pancreatic cancer biomarkers and uses thereof
|
LT2621526T
(en)
|
2010-09-29 |
2018-09-25 |
Agensys, Inc. |
Antibody drug conjugates (adc) that bind to 191p4d12 proteins
|
CN103313990B
(en)
|
2010-11-17 |
2016-07-20 |
基因泰克公司 |
Alanyl maytansinol antibody coupling matter
|
RS59080B1
(en)
|
2011-03-31 |
2019-09-30 |
Adc Therapeutics Sa |
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
|
EP2707723B1
(en)
|
2011-05-12 |
2016-02-10 |
Genentech, Inc. |
Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature pepides
|
MX350152B
(en)
|
2011-10-14 |
2017-08-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof.
|
PL2802351T3
(en)
|
2012-01-09 |
2019-11-29 |
Adc Therapeutics Sa |
Agents for treating triple negative breast cancer
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
EP2906297B1
(en)
|
2012-10-12 |
2017-12-06 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
US9931414B2
(en)
|
2012-10-12 |
2018-04-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
US10751346B2
(en)
|
2012-10-12 |
2020-08-25 |
Medimmune Limited |
Pyrrolobenzodiazepine—anti-PSMA antibody conjugates
|
CA2887897C
(en)
|
2012-10-12 |
2020-02-18 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine-anti-cd25 antibody conjugates
|
PL2839860T3
(en)
|
2012-10-12 |
2019-10-31 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
HUE035694T2
(en)
|
2012-10-12 |
2018-05-28 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
|
ES2680153T3
(en)
|
2012-10-12 |
2018-09-04 |
Adc Therapeutics Sa |
Anti-PSMA-pyrrolobenzodiazepine antibody conjugates
|
US9562049B2
(en)
|
2012-12-21 |
2017-02-07 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
CN105246894A
(en)
|
2012-12-21 |
2016-01-13 |
斯皮罗根有限公司 |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
CA2904044C
(en)
|
2013-03-13 |
2020-03-31 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
SG11201507214SA
(en)
|
2013-03-13 |
2015-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
BR112015023333A8
(en)
|
2013-03-13 |
2018-04-17 |
Medimmune Ltd |
pyrrolbenzodiazepines and conjugates thereof
|
EP2968988A4
(en)
|
2013-03-14 |
2016-11-16 |
Allegro Diagnostics Corp |
Methods for evaluating copd status
|
US11976329B2
(en)
|
2013-03-15 |
2024-05-07 |
Veracyte, Inc. |
Methods and systems for detecting usual interstitial pneumonia
|
MX2016001862A
(en)
|
2013-08-12 |
2016-08-03 |
Genentech Inc |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment.
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
US9950078B2
(en)
|
2013-10-11 |
2018-04-24 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
WO2015052535A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
WO2015052532A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
MX2016007578A
(en)
|
2013-12-16 |
2016-10-03 |
Genentech Inc |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment.
|
CR20160271A
(en)
|
2013-12-16 |
2016-12-02 |
Genentech Inc |
PEPTIDOMETIC COMPOUNDS AND THEIR ANTIBODY-DRUG CONJUGATES
|
EP3082874A2
(en)
|
2013-12-16 |
2016-10-26 |
Genentech, Inc. |
Peptidomimetic compounds and antibody-drug conjugates thereof
|
JP6531166B2
(en)
|
2014-09-10 |
2019-06-12 |
メドイミューン・リミテッドMedImmune Limited |
Pyrrolobenzodiazepine and its conjugate
|
BR112017003236A2
(en)
|
2014-09-12 |
2017-11-28 |
Genentech Inc |
cysteine engineered antibodies, drug conjugates and antibodies, drug and antibody conjugate preparation method and pharmaceutical composition
|
CN106714844B
(en)
|
2014-09-12 |
2022-08-05 |
基因泰克公司 |
Anthracycline disulfide intermediates, antibody-drug conjugates and methods
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
AU2015317653A1
(en)
|
2014-09-17 |
2017-04-06 |
Genentech, Inc. |
Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
|
US20170335396A1
(en)
|
2014-11-05 |
2017-11-23 |
Veracyte, Inc. |
Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
|
CN107148285B
(en)
|
2014-11-25 |
2022-01-04 |
Adc治疗股份有限公司 |
Pyrrolobenzodiazepine-antibody conjugates
|
MX2017007169A
(en)
|
2014-12-03 |
2018-05-02 |
Genentech Inc |
Quaternary amine compounds and antibody-drug conjugates thereof.
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
PL3388075T3
(en)
|
2015-03-27 |
2023-12-11 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against various tumors (seq id 25 - mrax5-003)
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
MA43345A
(en)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
|
MA43354A
(en)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
CONJUGATE DRUG CONJUGATES WITH CLOUDY DISULPHIDE
|
MA45326A
(en)
|
2015-10-20 |
2018-08-29 |
Genentech Inc |
CALICHEAMICIN-ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
GB201603568D0
(en)
*
|
2016-03-01 |
2016-04-13 |
Immatics Biotechnologies Gmbh |
Efficient treatment options including peptides and combination of peptide and cell based medicaments for use in immunotherapy against urinary bladder cancer
|
EP3433621A1
(en)
|
2016-03-25 |
2019-01-30 |
H. Hoffnabb-La Roche Ag |
Multiplexed total antibody and antibody-conjugated drug quantification assay
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
EP3458101B1
(en)
|
2016-05-20 |
2020-12-30 |
H. Hoffnabb-La Roche Ag |
Protac antibody conjugates and methods of use
|
WO2017205741A1
(en)
|
2016-05-27 |
2017-11-30 |
Genentech, Inc. |
Bioanalytical method for the characterization of site-specific antibody-drug conjugates
|
EP3464280B1
(en)
|
2016-06-06 |
2021-10-06 |
F. Hoffmann-La Roche AG |
Silvestrol antibody-drug conjugates and methods of use
|
US10927417B2
(en)
|
2016-07-08 |
2021-02-23 |
Trustees Of Boston University |
Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions
|
CN109689111B
(en)
|
2016-08-11 |
2024-04-05 |
基因泰克公司 |
Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof
|
CN110139674B
(en)
|
2016-10-05 |
2023-05-16 |
豪夫迈·罗氏有限公司 |
Method for preparing antibody drug conjugates
|
TWI762516B
(en)
|
2016-10-06 |
2022-05-01 |
日商腫瘤療法 科學股份有限公司 |
Monoclonal antibodies against FZD10 and their uses
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
TW201839136A
(en)
|
2017-02-06 |
2018-11-01 |
瑞士商諾華公司 |
Compositions and methods for the treatment of hemoglobinopathies
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
DK3544636T3
(en)
|
2017-02-08 |
2021-05-10 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine antibody conjugates
|
DK3612537T3
(en)
|
2017-04-18 |
2022-08-08 |
Medimmune Ltd |
PYRROLOBENZODIAZEPIN CONJUGATES
|
PL3612234T3
(en)
|
2017-04-20 |
2024-09-02 |
Adc Therapeutics Sa |
Combination therapy with an anti-axl antibody-drug conjugate
|
EP3638373B1
(en)
|
2017-06-14 |
2024-09-04 |
ADC Therapeutics SA |
Dosage regimes for the administration of an anti-cd19 adc
|
ES2906965T3
(en)
|
2017-08-18 |
2022-04-21 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
EP3684773A1
(en)
|
2017-09-20 |
2020-07-29 |
pH Pharma Co., Ltd. |
Thailanstatin analogs
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
GB201814281D0
(en)
|
2018-09-03 |
2018-10-17 |
Femtogenix Ltd |
Cytotoxic agents
|
EP3870235A1
(en)
|
2018-10-24 |
2021-09-01 |
F. Hoffmann-La Roche AG |
Conjugated chemical inducers of degradation and methods of use
|
CN113227119A
(en)
|
2018-12-10 |
2021-08-06 |
基因泰克公司 |
Photocrosslinked peptides for site-specific conjugation to Fc-containing proteins
|
GB201901197D0
(en)
|
2019-01-29 |
2019-03-20 |
Femtogenix Ltd |
G-A Crosslinking cytotoxic agents
|
GB2597532A
(en)
|
2020-07-28 |
2022-02-02 |
Femtogenix Ltd |
Cytotoxic compounds
|
CN114163510A
(en)
*
|
2021-03-24 |
2022-03-11 |
深圳市新靶向生物科技有限公司 |
Antigenic peptide combination related to liver cancer driver gene mutation and application thereof
|
EP4294951A1
(en)
*
|
2022-05-13 |
2023-12-27 |
Hummingbird Diagnostics GmbH |
Novel rna molecule for cancer detection
|
WO2024138128A2
(en)
|
2022-12-23 |
2024-06-27 |
Genentech, Inc. |
Cereblon degrader conjugates, and uses thereof
|